FDA — authorised 24 July 2003
- Application: NDA021535
- Marketing authorisation holder: GALDERMA LABS LP
- Local brand name: CLOBEX
- Indication: LOTION — TOPICAL
- Status: approved
🇺🇸 Clobetasol Propionate 0.05% Lotion in United States
FDA authorised Clobetasol Propionate 0.05% Lotion on 24 July 2003
Marketing authorisations
FDA — authorised 27 October 2005
- Application: NDA021835
- Marketing authorisation holder: GALDERMA LABS LP
- Local brand name: CLOBEX
- Indication: SPRAY — TOPICAL
- Status: approved
Frequently asked questions
Is Clobetasol Propionate 0.05% Lotion approved in United States?
Yes. FDA authorised it on 24 July 2003; FDA authorised it on 27 October 2005.
Who is the marketing authorisation holder for Clobetasol Propionate 0.05% Lotion in United States?
GALDERMA LABS LP holds the US marketing authorisation.